| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shao Wei-Ming | EVP & General Counsel | C/O MICROSTRATEGY INCORPORATED, 1850 TOWERS CRESCENT PLAZA, TYSONS CORNER | /s/ Allein Sabel, Attorney-in-Fact | 15 Jul 2025 | 0001663488 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MSTR | Class A Common Stock | Options Exercise | $404,600 | +10,000 | +79% | $40.46 | 22,726 | 11 Jul 2025 | Direct | |
| transaction | MSTR | Class A Common Stock | Sale | $85,016 | -200 | -0.88% | $425.08 | 22,526 | 11 Jul 2025 | Direct | F1 |
| transaction | MSTR | Class A Common Stock | Sale | $171,245 | -401 | -1.8% | $427.04 | 22,125 | 11 Jul 2025 | Direct | F2 |
| transaction | MSTR | Class A Common Stock | Sale | $379,593 | -886 | -4% | $428.43 | 21,239 | 11 Jul 2025 | Direct | F3 |
| transaction | MSTR | Class A Common Stock | Sale | $421,177 | -981 | -4.6% | $429.33 | 20,528 | 11 Jul 2025 | Direct | F4 |
| transaction | MSTR | Class A Common Stock | Sale | $961,864 | -2,235 | -11% | $430.36 | 18,023 | 11 Jul 2025 | Direct | F5 |
| transaction | MSTR | Class A Common Stock | Sale | $255,295 | -592 | -3.3% | $431.24 | 17,431 | 11 Jul 2025 | Direct | F6 |
| transaction | MSTR | Class A Common Stock | Sale | $207,536 | -480 | -2.8% | $432.37 | 16,951 | 11 Jul 2025 | Direct | F7 |
| transaction | MSTR | Class A Common Stock | Sale | $548,148 | -1,264 | -7.5% | $433.66 | 15,687 | 11 Jul 2025 | Direct | F8 |
| transaction | MSTR | Class A Common Stock | Sale | $479,703 | -1,104 | -7% | $434.51 | 14,583 | 11 Jul 2025 | Direct | F9 |
| transaction | MSTR | Class A Common Stock | Sale | $509,485 | -1,169 | -8% | $435.83 | 13,414 | 11 Jul 2025 | Direct | F10 |
| transaction | MSTR | Class A Common Stock | Sale | $213,220 | -488 | -3.6% | $436.93 | 12,926 | 11 Jul 2025 | Direct | F11 |
| transaction | MSTR | Class A Common Stock | Sale | $87,565 | -200 | -1.5% | $437.82 | 12,726 | 11 Jul 2025 | Direct | F12 |
| holding | MSTR | Series A Perpetual Stride Preferred Stock | 3,527 | 11 Jul 2025 | Direct | ||||||
| holding | MSTR | Series A Perpetual Strife Preferred Stock | 500 | 11 Jul 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MSTR | Employee Stock Option (Right to buy) | Options Exercise | $0 | -10,000 | -6.2% | $0.000000 | 150,000 | 11 Jul 2025 | Class A Common Stock | 10,000 | $40.46 | Direct | F13 |
| Id | Content |
|---|---|
| F1 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $425.00 to $425.16, inclusive. The reporting person undertakes to provide to MicroStrategy Incorporated d/b/a Strategy ("Strategy"), any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $426.72 to $427.55, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $427.81 to $428.79, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F4 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.90 to $429.88, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F5 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $429.91 to $430.90, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F6 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $430.92 to $431.70, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F7 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $432.14 to $432.95, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F8 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $433.18 to $433.96, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F9 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $434.18 to $435.07, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F10 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $435.50 to $436.24, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F11 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $436.71 to $437.39, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F12 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $437.82 to $437.83, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F13 | The 10,000 shares exercised on July 11, 2025 pursuant to this option vested on February 17, 2023. Of the remaining 150,000 shares subject to this option, 50,000 shares vested on February 17, 2024, 50,000 shares vested on February 17, 2025 and 50,000 shares are scheduled to vest on February 17, 2026. |